Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report

RATIONALE: Membranous glomerulonephritis (MN) is the leading cause of nephrotic syndrome in adults and is classified as primary or secondary. Secondary MN accounts for 20% to 30% of all MN cases and can arise from a number of conditions, including autoimmune diseases. Recently exostosin 1/exostosin...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ling, Yang, Zhi, Tao, Tian, Yang, Mei, Hu, Zhang-Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939150/
https://www.ncbi.nlm.nih.gov/pubmed/33655949
http://dx.doi.org/10.1097/MD.0000000000024887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939150/
https://www.ncbi.nlm.nih.gov/pubmed/33655949
http://dx.doi.org/10.1097/MD.0000000000024887

Ejemplares similares